LangFangshi Zekang Pharma Tech CO.,Itd.
Firmenname:
LangFangshi Zekang Pharma Tech CO.,Itd.
Telefon:
0316-2883536
E-Mail:
1877241811@qq.com
Nationalität:
China
URL:
www.chemicalbook.com/showsupplierproductslist1466071/0.htm
Produkte insgesamt:
1375
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Produktkatalog
1-METHYLHYDANTOIN
1-Methyldiazolidin-2,4-dion
616-04-6
C4H6N2O2
oxiracetam impurity III
62833-66-3
C6H8N2O2
(R)-4-Hydroxy-2-pyrrolidone
25747-41-5
C4H7NO2
(R)-4-Hydroxy-2-pyrrolidone
62624-29-7
C4H7NO2
GLYCINE ANHYDRIDE
Piperazin-2,5-dion
106-57-0
C4H6N2O2
oxiracetaM related substance ISF3886
120428-80-0
C8H13N3O4
oxiracetam impurity VII
Ethyl-4-hydroxy-2-oxopyrrolidin-1-acetat
62613-81-4
C8H13NO4
Dabigatran Etexilate Impurity 64
355809-32-4
C9H10N2O3
Dabigatran Etexilate Impurity 67
1848337-06-3
C24H29N5O4
Dabigatran etexilate Impurity R
1610758-20-7
C34H41N7O5
Desethyl Dabigatran Etexilate
212321-78-3
C32H37N7O5
Dabigatran iMpurity F
1642853-67-5
C19H20N4O4
INDEX NAME NOT YET ASSIGNED
2518152-88-8
C28H28N6O3
Dabigatran Impurity 18
1422435-35-5
C21H23N3O4
Dabigatran Impurity 9
1408238-41-4
C19H21N5O2
Dabigatran etexilate Imp.C
1408238-40-3
C34H40N6O6
Dabigatran Impurity 24
2243727-83-3
C38H49N7O5
Dabigatran Impurity 10 (DABRC-10)
1304574-20-6
C35H43N7O5
1H-Benzimidazole-5-carboxylic acid, 2-[[(4-cyanophenyl)amino]methyl]-1-methyl-, methyl ester
1970195-83-5
C18H16N4O2
Dabigatran iMpurity G
1912458-32-2
C24H29N5O4
1H-Benzimidazole-5-carboxylic acid, 2-[[[4-[(E)-amino[[(hexyloxy)carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl-
2459303-30-9
C24H29N5O4
Dabigatran iMpurity E
1456889-80-7
C20H22N4O3
Dabigatran Etexilate Impurity H
211915-00-3
C33H39N7O5
1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-(methylamino)-1-[(4-methyl-2-quinazolinyl)methyl]-
2468656-63-3
C21H21N7O2
Vardenafil Impurity 7
1009013-42-6
C19H25N5O4S
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-5,7-dimethyl-
224785-72-2
C20H26N6O4S
benzofuran-6-carboxylic acid(Lifitegrast Impurity 29)
77095-51-3
C9H6O3
Acetylvardenafil
1261351-28-3
C25H34N6O3
ethyl benzofuran-6-carboxylate
1289646-90-7
C11H10O3
Linagliptin Impurity 14
2416949-69-2
C25H29N7O4
(S)-2-(tert-butoxycarbonylamino)-3-(3-(methylsulfonyl)phenyl) propanoic acid
1289646-76-9
C15H21NO6S
4-Aminobenzamidine dihydrochloride
4-Aminobenzamidindihydrochlorid
2498-50-2
C7H11Cl2N3
C3-NITRO-4-METHYLAMINO-BENZOYLCHLORIDE
82357-48-0
C8H7ClN2O3
Dabigatran Impurity
2096992-14-0
C34H41N7O5
Dabigatran iMpurity D
1610758-22-9
C34H41N7O5
Dabigatran Impurity 10
1422435-37-7
C21H24N4O3
Dabigatran Etexilate iMpurity 1
1610758-19-4
C35H43N7O5
N,N-DIMETHYL-GUANIDINE
6145-42-2
C3H9N3
Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate
212322-56-0
C18H22N4O3
Cyanamide, N,N-dicyano-
97904-31-9
C3N4
3-(pyridin-2-ylamino)propanoic acid
104961-64-0
C8H10N2O2
Dabigatran Etexilate Impurity 82
1771756-20-7
C16H18N4O3
N-[3-AMino-4-(MethylaMino)benzoyl]-N-2-pyridinyl-β-alanine Methyl Ester
1369510-38-2
C17H20N4O3
Dabigatran Etexilate iMpurity D
1422435-40-2
C19H20N4O3
ethyl 3-(2-(((4-(ethoxy(imino)methyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride
1354727-65-3
C29H33ClN6O4
Dabigatran Etexilate iMpurity C4
1416446-43-9
C32H37N7O5
ethyl 3-(2-(chloroMethyl)-1-Methyl-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-carboxaMido)propanoate
1307233-94-8
C20H21ClN4O3
β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, methyl ester
771459-37-1
C26H27N7O3
Dabigatran Etexilate iMpurity O
1349500-09-9
C35H43N7O5
N-Desethyl-N-Methyl Vardenafil
224785-87-9
C22H30N6O4S
midazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(2-hydroxyphenyl)-5-methyl-7-propyl-
910554-78-8
C15H16N4O2
1-Methylguanidine hydrochloride
21770-81-0
C2H8ClN3
Dibanzyloxy phosphatecreatinine
Dibenzyl-(1-methyl-4-oxoimidazolidin-2-yliden)phosphoramidat
19208-69-6
C18H20N3O4P
Sodium sarcosinate
Natriumsarkosinat
4316-73-8
C3H8NNaO2
4-hydroxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazine-2-yl)phenylsulfonic acid
910554-77-7
C15H16N4O5S
Linagliptin impurity 16
1955514-80-3
C26H29N9O3
Vardenafil Impurity 13
2169247-39-4
C21H28N6O4S
2,2'-((piperazine-1,4-disulfonyl)bis(2-ethoxy-5,1-phenylene))bis(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one)
1255919-03-9
C38H46N10O8S2
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(2-ethoxyphenyl)-5,7-dimethyl-
224789-20-2
C15H16N4O2
N-[1-[3-(2-Ethoxyphenyl)-2,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl]acetamide
1417529-59-9
C15H18N4O3
N-Desethyl Vardenafil
448184-46-1
C21H28N6O4S
Hydroxyvardenafil
224785-98-2
C23H32N6O5S
VARDENAFIL, DIHYDROCHLORIDE SALT
224788-34-5
C22H29N5O4S
Linagliptin Impurity H
1646355-34-1
C22H23N7O2
2-QuinazolineMethanol, 4-Methyl-
13535-91-6
C10H10N2O
Linagliptin Impurity 51
2138392-83-1
C26H21BrN8O2
Vardenafil EP Impurity B
437717-43-6
C17H20N4O5S
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-ethyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl-
448184-48-3
C23H32N6O5S
INDEX NAME NOT YET ASSIGNED
2748491-45-2
C21H24N8O2
Linagliptin Impurity D
666816-91-7
C20H28N6O4
Linagliptin Impurity F
1673546-62-7
C27H27F3N8O3
Linagliptin iMpurity E
1446263-38-2
C25H28N8O2
Linagliptin Impurity K
1638744-06-5
C25H29BrN8O2
Linagliptin Impurity 33
2443735-53-1
C38H42N10O4
Linagliptin N-Acetyl Impurity
1803079-49-3
C27H30N8O3
Linagliptin Impurity 3
2749409-37-6
C19H24N6O2
Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate (Dabigatran IMpurity)
1408238-36-7
C26H33N5O4
Dabigatran iMpurity K
1580491-16-2
C32H38N8O4
Dabigatran Impurity 5
2225986-95-6
C34H41N7O5
Dabigatran Impurity 38
1416446-40-6
C30H33N7O5
Dabigatran Etexilate Impurity O HCl
211914-50-0
C27H30ClN7O3
β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, labeled with tritium
1919877-45-4
C25H25N7O3
Dabigatran Etexilate Impurity X
1643377-48-3
C25H26N8O2
Dabigatran Etexilate Impurity B
211914-51-1
C25H25N7O3
β-Alanine, N-[[2-[[[4-[(E)-amino[[[(4-methylpentyl)oxy]carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester
1873316-88-1
C34H41N7O5
Dabigatran Impurity 29
1610758-21-8
C35H43N7O5
Dabigatran Impurity p
1408238-37-8
C32H36N6O6
Dabigatran Etexilate iMpurity I
255706-13-9
C14H21N3O2
Dabigatran Impurity 19
2225986-94-5
C34H41N7O5
Dabigatran etexilate C5
1416446-45-1
C33H39N7O5
Dabigatran Etexilate iMpurity H
1702936-92-2
C19H20N4O3
Dabigatran Impurity 16
211916-39-1
C26H24N6O3
Dabigatran iMpurity O
948551-71-1
C27H28N6O4
Dabigatran iMpurity L
1422435-41-3
C27H28N6O4
β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, hydrochloride (1:)
1187067-70-4
C27H30ClN7O3
Dabigabine mesylate - intermediate 2
1223061-75-3
C27H30ClN7O3
Clobetasone
Clobetason
54063-32-0
C22H26ClFO4
9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate
9-Fluor-11β,17,21-trihydroxy-16β-methylpregna-1,4-dien-3,20-dion-17-propionat
5534-13-4
C25H33FO6
oxiracetam impurity IV
77191-37-8
C6H9NO4
oxiracetam impurity VI
85614-52-4
C7H11NO4
(R)-4-Hydroxy-2-pyrrolidone
22677-21-0
C4H7NO2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Copyright 2019 © ChemicalBook. All rights reserved